Pulmonary fibrosis is a severely disabling disease often leading to death. CCN2 (Cellular Communication Network factor 2, also known as CTGF) is a known mediator of fibrosis and clinical trials studying anti-CCN2 efficacy in pulmonary fibrosis are currently underway. Fork head box D1 (FoxD1) transcription factor is transiently expressed in several mesenchymal cell types, including those of fetal lungs. Differentiation of FoxD1-progenitor derived pericytes into myofibroblasts involves CCN2 expression and contributes importantly to maladaptive tissue remodeling in e.g. kidney and lung fibrosis models. To generate a model for studying the contribution of CCN2 expression in FoxD1-progenitor derived cells to development of fibrotic tissue remodeling, we set out to establish a FoxD1Cre -CCN2 flox/flox mouse colony. However, all double-transgenic mice died soon after birth due to asphyxia. Histopathological examination revealed a reduction in alveolar space and lung weight, and subtle axial (thoracic and cervical) skeletal deformities. Together with the previously reported association of a FoxD1 containing locus with human adolescent idiopathic scoliosis, our data suggest that the development of fatal pulmonary hypoplasia caused by selective deletion of CCN2 from FoxD1-progenitor derived mesenchymal cells was secondary to aberrant axial skeletogenesis.
Introduction
Pulmonary fibrosis is a very severe and life-threatening disease characterized by interstitial fibrosis in the lung parenchyma leading to reduced lung and diffusion capacity, with consequent respiratory failure and often death. Fibrosis is the final common pathway of maladaptive tissue remodeling and loss of organ function.
Cellular Communication Network factor 2 (CCN2; also known as Connective Tissue Growth Factor, CTGF) is an important mediator of fibrosis in virtually all organs, including the kidneys and the lungs (Pan et al. 2001; Wang et al. 2019) . Myofibroblasts are the main effector cells during tissue fibrosis. Transformation of mesenchyme derived lung pericytes contributes importantly to the increase in myofibroblast numbers during pulmonary and kidney fibrosis a process known to be CCN2 dependent (Shiwen et al. 2009; Hung et al. 2013) .
Fork head box D1 (FoxD1) transcription factor expression is transiently expressed in multiple mesenchymal cell types in several organs. FoxD1-derived mesenchymal cells, especially pericytes, contribute importantly to e.g. experimental kidney
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In order to generate a tool for the study of CCN2 expression by FoxD1-lineage cells to fibrotic tissue remodeling, we set out to establish a colony of FoxD1cre-CCN2 flox/flox mice. Surprisingly however, FoxD1cre mediated homozygous CCN2 deletion induced an early postnatal fatal phenotype characterized by pulmonary hypoplasia and postnatal asphyxiation. Moreover, subtle axial skeletal defects were observed possibly underlying the pulmonary phenotype.
Materials and methods

Animals
The generation processes of FoxD1Cre and CCN2flox mice has been described extensively elsewhere (Liu et al. 2011; Kobayashi et al. 2014 ). FoxD1Cre and homozygous CCN2flox mice were cross-bred at least 5 generations prior to conduction of experiments. FoxD1Cre -CCN2 flox/flox pups were severely asphyctic and euthanized by decapitation. Heterozygous (FoxD1Cre-CCN2 flox/+ ) littermates showed no abnormalities, consistent with lack of a spontaneous phenotype in heterozygous constitutive CCN2 knockouts (Ivkovic et al. 2003) . In subsequent experiments, mothers were killed before delivery on embryonic day (E)18.5 to prevent confounding secondary postnatal pathology. All fetuses in these litters were killed by decapitation immediately after opening the womb.
Immunohistochemistry
Whole embryos or selected tissues were embedded in paraffin blocks. Of these, 4 μm sections were cut, mounted on object slides and deparaffinized/rehydrated using sequential rinsing in xylene and 100%, 90% and 70% EtOH. Hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) staining were performed using standard protocols as used in diagnostics at the department of pathology. CD31/PDGFRβ double staining was performed as followed: Citrate (pH 6) boiling antigen retrieval (20 min), PBS(T) rinsing, anti-CD31 primary antibody incubation (LS-B4737 (LS Bio, Seattle WA); 1:50, 1.5 h room temperature), PBS(T) rinsing, Brightvision-AP (Immunologic, Duiven, the Netherlands) secondary antibody incubation (1 h), PBS(T) rinsing, Liquid permanent red (ThermoFisher, Waltham, MA) substrate development, PBS rinsing, Citrate boiling antigen retrieval (10 min), PBS(T) rinsing, anti-PDGFRβ primary antibody incubation (NB100-57343 (Novus, Contennial, CO); 1:200, overnight 4 C), PBS(T) rinsing, Brightvision-AP incubation (45 min), PBS(T) rinsing, Vector Blue (Vector, Burlingame, CA) substrate development, PBS rinsing, drying, xylene, coverslip.
RT-qPCR
RNA was isolated from tissues using Trizol (ThermoFisher), and 3000 ng was reversely transcribed into cDNA. RT-qPCR was performed on a LightCycler480 (Roche, Basel, Switzerland), using commercially available TaqMan primer assays (Col1a2, Mm00483888_m1; Ccn2, Mm01192933_g1; Elastin, Mm00514692_m1; Thermo Fisher).
Whole mount skeletal stain
Whole mount skeletal staining protocol of fetal carcasses is extensively described elsewhere (Rigueur and Lyons 2014) . Briefly, wholemounts were rinsed, and fixed in ethanol (95%) and acetone respectively. Cartilage was stained by Alcian blue immersion, after which mounts were rinsed in 70% and 95% EtOH respectively. Using potassium hydroxide (KOH; 1% w/v), mounts were pre-cleared. Alizarin red was used to stain calcified bone. This was followed by immersion in KOH/glycerol (1:1) solution to remove excess red staining before storage in glycerol.
Statistics
Statistical significance between groups was tested using the Student-T test using GraphPad Prism Version 8.0.1 (GraphPad, San Diego, CA). A P value below 0.05 was considered statistically significant. Error bars represented SEM.
Ethics
All experiments were conducted with permission of the animal ethics committee of the University of Utrecht.
Results
FoxD1Cre driven CCN2 deletion leads to impaired lung development and postnatal asphyxia but unaltered expression of structural proteins Upon birth, FoxD1Cre/CCN2flox pups showed a slight thoracic kyphosis and made gasping movements, became cyanotic and severely asphyctic (Supplemental Video 1). They were euthanized by decapitation. Body weight after birth was similar in both FoxD1Cre/CCN2 flox/flox and WT/CCN2 flox/flox groups (average 1.4-g, SEM ± 0.3). However, the lung to body weight ratio was reduced in FoxD1Cre/ CCN2 flox/flox mice (WT/ CCN2 flox/flox : 41.58 mg/g SEM± 1.28 and FoxD1Cre/ CCN2 flox/flox : 36.23 mg/g SEM± 1.49 respectively; P < 0.05).
Analysis of PAS stained lung sections showed reduced potential airspace compared to WT/CCN2flox mice (P < 0.05; Fig. 1a, b ). CD31 (endothelium) and PDGFRβ (pericytes) revealed no aberrancies in the endothelial/pericyte interface in FoxD1Cre/CCN2flox mice (Fig. 1c) .
Type Ipneumocytes arethemost abundant celltype in thelungs. Podoplanin mRNA expression level as a surrogate marker for type I pneumocyte numbers, showed no difference between WT/ CCN2flox/flox and FoxD1Cre/CCN2flox/flox mice (Fig. 1d) .
The expression of Col1α2 mRNA was not significantly different (Fig. 1e) , and also hydroxyproline/proline content was similar in both groups (Fig. 1f ). The expression level of Elastin mRNA was significantly reduced in FoxD1Cre/ CCN2 flox/flox mice (P < 0.05; Fig. 1g ), but mass spectrometry analysis of isodesmin as a marker for elastin fibrils showed no significant difference (Fig. 1h ).
CCN2 deletion in FoxD1-lineage derived cells in the lung does not affect pulmonary CCN2 mRNA expression level at late gestation
CCN2flox genotyping PCR of lung parenchyma at E18.5 shows a profound knock-out (KO) DNA band in FoxD1Cre positive CCN2flox/flox mice ( Fig. 2a ), indicating FoxD1Cre driven CCN2 recombination has occurred before E18.5. However, at E18.5 total pulmonary CCN2 mRNA expression was not significantly lower compared to WT/CCN2flox mice (P = 0.07; Fig. 2b ). This suggests that the contribution pulmonary FoxD1 lineage cells make to CCN2 production in the lung at this late developmental stage is limited. (Fig. 3a, b ; P < 0.01). Additionally, the sternal length of FoxD1Cre/ CCN2 flox/flox mice was significantly shorter when compared to WT/ CCN2flox mice ( Fig. 3c, d ; P < 0.05).
Global microscopic assessment of Alcian blue, Collagen type 2 and Ki67 (immuno)histochemistry however showed no apparent differences in FoxD1Cre/ CCN2 flox/flox compared to the WT/CCN2 flox/flox littermates (data not shown).
CCN2flox PCR showed a much more pronounced KO band in fetal tail-, than liver DNA, suggesting that FoxD1lineage cells contribute significantly to CCN2-expression during axial skeletal development (Fig. 3e) . 
Discussion
Here we show that loss of CCN2 from FoxD1-lineage cells leads to aberrant lung morphology with post-natal asphyxiation, and axial skeletal deformities.
In postnatal lungs, CCN2 is mainly expressed in terminal bronchiolar epithelium (Burgos et al. 2010 ), which does not derive from FoxD1 expressing progenitor cells (Hung et al. 2013) . This explains why CCN2 expression levels are not altered significantly in E18.5 FoxD1Cre/CCN2 flox/flox lungs (Fig.  2) . The lung hypoplasia in our FoxD1Cre/CCN2 flox/flox mice is very similar to that in constitutive CCN2-knock out mice. CCN2 is expressed in the developing lung (Burgos et al. 2010) , and it has been proposed that in constitutive CCN2 -KO mice the absence of pulmonary CCN2 expression in the developing lung itself contributes importantly to pulmonary hypoplasia (Baguma-Nibasheka and Kablar 2008), but the lung hypoplasia in constitutive CCN2-knock out mice has also been interpreted as being secondary to their profound skeletal deformities (Ivkovic et al. 2003; Baguma-Nibasheka and Kablar 2008) .
Normal lung development requires a structurally welldeveloped thorax (Inanlou et al. 2005 ) (Cameron et al. 2009 ). As an important regulator of enchondral ossification, CCN2 is critically involved in normal skeletal development as evidenced by severe malformations in constitutive CCN2-knockout mice (Kubota and Takigawa 2007) (Ivkovic et al. 2003; Baguma-Nibasheka and Kablar 2008) . Similarly, the axial skeletal deformities in our FoxD1Cre/CCN2 flox/flox mice are most likely the direct effect of CCN2 silencing in FoxD1-lineage cells in the developing axial skeleton. This would also be consistent with the reported co-segregation of a human chromosome region spanning 5q13.2 to 13.4 including the FOXD1 gene, as a locus co-segregating with disease in multiple generations of a family with idiopathic scoliosis (Edery et al. 2011) .
The similarity of the pulmonary phenotype of constitutive CCN2-knock out mice with the impaired development of fetal lungs of FoxD1Cre-CTGF flox/flox embryos in the current study suggests that also in the latter lung hypoplasia might have developed secondary to the skeletal deformities.
In summary, we report that targeted CCN2 deletion in cells expressing FoxD1 during embryonic development leads to a lethal phenotype associated with axial skeletal deformities and postnatal asphyxiation due to (possibly secondary) pulmonary hypoplasia.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
